Aspira Pathlab & Diagnostics Ltd 540788.BO
Last Updated: Jul 17, 12:00 AM·BSE
540788.BO Shariah Compliance
Screening Methodology: AAOIFI
As of July 2026, Aspira Pathlab & Diagnostics Ltd is classified as halal.
HALAL
Report Source: 2026 2nd Quarter Report
Aspira Pathlab & Diagnostics Ltd. Stock Analysis 540788.BO
India N/A Nano Cap Report: Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-12-05. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The firm carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The firm's tests include pathology test, sonography, x-ray, and radiology. Its pathology tests include Influenza (Flu) Panel with H3N2, Blood chromosome analysis, Filmarray multiplex PCR(BIOFIRE) Pneumonia Panel Plus, Polycystic Ovarian Syndrome (PCOS) 2, Typhoid PCR, Dengue-Chikungunya-Malaria multiplex PCR, Vitamin And TSH, Fever screening profile-2, and others.
Read More Aspira Pathlab & Diagnostics Ltd (540788.BO) Chart
Key Statistics of Aspira Pathlab & Diagnostics Ltd (540788.BO)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹85.95Volume
101.48KP/E Ratio (TTM)
2,620.4052 Week Range
Market Cap
1.23BAvg. Volume
7561.05Dividend Yield
-Financial Metrics & Statements of Aspira Pathlab & Diagnostics Ltd (540788.BO)
Super Investors Invested in Aspira Pathlab & Diagnostics Ltd (540788.BO)
FAQ's for Aspira Pathlab & Diagnostics Ltd (540788.BO)
- As of July 2026, Aspira Pathlab & Diagnostics Ltd 540788.BO is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aspira Pathlab & Diagnostics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Aspira Pathlab & Diagnostics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Aspira Pathlab & Diagnostics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Aspira Pathlab & Diagnostics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Aspira Pathlab & Diagnostics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.